Request Demo
Last update 17 Apr 2026
QHL-1618
Last update 17 Apr 2026
Overview
Basic Info
Drug Type Small molecule-drug conjugates |
Synonyms ALK-N001, ALKN001, QHL 1618 + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Boost your research with our ADC technology data.
login
or
Related
2
Clinical Trials associated with QHL-1618NCT07509684
An Open-label, Multicenter Phase Ib/II Study Evaluating the Efficacy, Safety and Pharmacokinetics of Injectable ALK-N001 in Patients With Advanced Solid Tumors
NCT07529535
An Open-label, Multicenter Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ALK-N001 for Injection in Patients With Advanced Solid Tumors
100 Clinical Results associated with QHL-1618
Login to view more data
100 Translational Medicine associated with QHL-1618
Login to view more data
100 Patents (Medical) associated with QHL-1618
Login to view more data
100 Deals associated with QHL-1618
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 05 Jun 2025 | |
| Breast Cancer | Phase 2 | China | 05 Jun 2025 | |
| Esophageal Squamous Cell Carcinoma | Phase 2 | China | 05 Jun 2025 | |
| Gastrooesophageal junction cancer | Phase 2 | China | 05 Jun 2025 | |
| Intestinal Neoplasms | Phase 2 | China | 05 Jun 2025 | |
| Ovarian Cancer | Phase 2 | China | 05 Jun 2025 | |
| Pancreatic Cancer | Phase 2 | China | 05 Jun 2025 | |
| Sarcoma | Phase 2 | China | 05 Jun 2025 | |
| Small Cell Lung Cancer | Phase 2 | China | 05 Jun 2025 | |
| Solid tumor | IND Approval | China | 01 May 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free